et al., J. Cellular Physiology,
study showing Ivermectin is a safe wide-spectrum antiviral against SARS-CoV-2, human papillomavirus (HPV), Epstein–Barr virus (EBV), and HIV.
Authors note that the combination of ivermectin and other drugs might result in more favorable prognoses for patients with COVID‐19, for example ivermerctin and HCQ.
Li et al., 9/22/2020, peer-reviewed, 3 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.